Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Metabolic Syndrome, Morbid Obesity, Hypercholesterolemia, Hyperglycemia

In brief

The goal of this clinical trial is to compare the efficacy of two different daily doses of tetrahydrocannabivarin impregnated mouth strips in healthy non-diabetic obese adults. The main questions to answer are: * Is the low dose treatment superior to placebo for losing weight, abdominal girth, cholesterol levels and blood glucose levels? * Is the low dose treatment superior to placebo for losing weight, abdominal girth, cholesterol levels and blood glucose levels? * Is one dose better than the other dose? Participants will take either the low dose, high dose or placebo dose daily for ninety days and have physical measurements and blood tests obtained at the beginning and the end of the study.

Key facts

Study ID

NCT05574049

Run by

Medical Life Care Planners, LLC

People needed

56

Starts

2022-01-04

Expected to finish

2022-05-04

Last updated by the study team

2022-10-10

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults who met the clinical criteria for obesity (BMI ≥ 30) without comorbid diabetes or cardiovascular disease were selected for this study.

You may not qualify if…

• Under age 18 BMI less than 30 presence of diabetes or cardiovascular disease.

Where it is running

• Hair and Scalp Clinic — Clearwater, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.